Mazzuti, Laura <br/><br/>
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors.  [electronic resource] 

 -  AIDS (London, England)  Aug 2017 
 - 1900-1901 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0000000000001581  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Resistance, Viral<br/>HIV Infections--drug therapy<br/>HIV Integrase--genetics<br/>HIV Integrase Inhibitors--administration & dosage<br/>HIV-1--enzymology<br/>Heterocyclic Compounds, 3-Ring--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation, Missense<br/>Oxazines<br/>Piperazines<br/>Pyridones<br/>Sustained Virologic Response<br/>Treatment Outcome